Reports also suggest that the interaction between Gal-9 and TIM-3 supports the maintenance of leukemia-initiating cells and promotes immune eversion in AML models (Goncalves Silva et al., 2017; Ruvolo, 2019; Gallazzi et al., 2022). Here, LGALS9 is linked to leukemia.